Kimball Hall

CIK: 0001897965

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VERA

Vera Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

VERA
Vera Therapeutics, Inc.
May 21, 2026
Award(A)
Stock Option (right to buy)
Direct
17.1K shares-
VERA
Vera Therapeutics, Inc.
May 14, 2025
Award(A)
Stock Option (right to buy)
Direct
14K shares-

		Type	Shares	Price		Ownership
May 21, 2026	VERA Vera Therapeutics, Inc.	Award(A) Stock Option (right to buy)	17,084	-	-	Direct
May 14, 2025	VERA Vera Therapeutics, Inc.	Award(A) Stock Option (right to buy)	14,000	-	-	Direct

1-2 of 2 transactions

About Hall Kimball

Hall Kimball (SEC CIK 0001897965) files insider reports with the SEC as Director of Vera Therapeutics, Inc. (VERA).

Signal8 holds 2 ownership filings by Hall Kimball, all Form 4s, filed between May 16, 2025 and May 26, 2026. Those filings report 2 transactions, from May 14, 2025 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hall Kimball's filings is in BRISBANE, CA.

Recent filings by Hall Kimball

May 21, 2026: Grant or award of VERA derivative securities (Form 4, code A).
May 14, 2025: Grant or award of VERA derivative securities (Form 4, code A).

Other insiders filing for Vera Therapeutics, Inc. (VERA)

Fordyce Marshall, PRESIDENT AND CEO
Young Joseph R, SVP, FINANCE, CHIEF ACCT OFFCR
Boman Nancy Lee, Chief Regulatory Officer
Morrison Scott W, Director
Cheng Andrew, Director
SEIDENBERG BETH C, Director

How to read Form 4 transaction codes